Amarin Corp Plc (AMRN)

[SocialBoom]

Ranexa from GILD is/was a billion dollar cardio drug that will soon go generic.

GILD is a mess with shrinking revenue misguided management and $29 Billion in cash on hand.

Last night's news of GILD's fail in NASH puts more and more pressure for them to find a bolt on or larger M&A deal to stem the bleeding.

They have an existing CV team, and could easily fold in the entire AMRN team from the sales reps to every member of management.

IMO, this is the space to watch. Makes as much or more sense than a lot of other potential players.

They have the resources to make Vascepa a household brand globally.